• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脉搏到达时间变化作为心脏再同步治疗急性反应的无创标志物。

Pulse arrival time variation as a non-invasive marker of acute response to cardiac resynchronization therapy.

机构信息

The Intervention Centre, Oslo University Hospital, Rikshospitalet, Postboks 4950 Nydalen, 0424 Oslo, Norway.

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

出版信息

Europace. 2023 Mar 30;25(3):1183-1192. doi: 10.1093/europace/euad013.

DOI:10.1093/europace/euad013
Abstract

AIMS

Successful cardiac resynchronization therapy (CRT) shortens the pre-ejection period (PEP) which is prolonged in the left bundle branch block (LBBB). In a combined animal and patient study, we investigated if changes in the pulse arrival time (PAT) could be used to measure acute changes in PEP during CRT implantation and hence be used to evaluate acute CRT response non-invasively and in real time.

METHODS AND RESULTS

In six canines, a pulse transducer was attached to a lower limb and PAT was measured together with left ventricular (LV) pressure by micromanometer at baseline, after induction of LBBB and during biventricular pacing. Time-to-peak LV dP/dt (Td) was used as a surrogate for PEP. In twelve LBBB patients during implantation of CRT, LV and femoral pressures were measured at baseline and during five different pacing configurations. PAT increased from baseline (277 ± 9 ms) to LBBB (313 ± 16 ms, P < 0.05) and shortened with biventricular pacing (290 ± 16 ms, P < 0.05) in animals. There was a strong relationship between changes in PAT and Td in patients (r2 = 0.91). Two patients were classified as non-responders at 6 months follow-up. CRT decreased PAT from 320 ± 41 to 298 ± 39 ms (P < 0.05) in the responders, while PAT increased by 5 and 8 ms in the two non-responders.

CONCLUSION

This proof-of-concept study indicates that PAT can be used as a simple, non-invasive method to assess the acute effects of CRT in real time with the potential to identify long-term response in patients.

摘要

目的

成功的心脏再同步治疗(CRT)可缩短左束支传导阻滞(LBBB)时延长的射血前期(PEP)。在一项联合动物和患者的研究中,我们研究了脉搏到达时间(PAT)的变化是否可用于测量 CRT 植入过程中 PEP 的急性变化,从而用于实时无创评估急性 CRT 反应。

方法和结果

在 6 只犬中,将脉搏传感器连接到下肢,通过微测压计同时测量 PAT 和左心室(LV)压力,在基线、诱导 LBBB 和双心室起搏时进行测量。LV 最大 dp/dt 时间(Td)被用作 PEP 的替代指标。在 12 例 LBBB 患者 CRT 植入过程中,在基线和 5 种不同起搏配置下测量 LV 和股动脉压力。PAT 从基线(277 ± 9 ms)增加到 LBBB(313 ± 16 ms,P < 0.05),并随双心室起搏而缩短(290 ± 16 ms,P < 0.05)。在患者中,PAT 变化与 Td 之间存在很强的相关性(r2 = 0.91)。2 例患者在 6 个月随访时被归类为无反应者。CRT 使反应者的 PAT 从 320 ± 41 降至 298 ± 39 ms(P < 0.05),而在 2 例无反应者中 PAT 分别增加了 5 和 8 ms。

结论

这项概念验证研究表明,PAT 可用作一种简单、无创的方法,实时评估 CRT 的急性效应,并有潜力识别患者的长期反应。

相似文献

1
Pulse arrival time variation as a non-invasive marker of acute response to cardiac resynchronization therapy.脉搏到达时间变化作为心脏再同步治疗急性反应的无创标志物。
Europace. 2023 Mar 30;25(3):1183-1192. doi: 10.1093/europace/euad013.
2
Shortening of time-to-peak left ventricular pressure rise (Td) in cardiac resynchronization therapy.左心室压力上升时间峰值缩短(Td)在心脏再同步治疗中的作用。
ESC Heart Fail. 2021 Dec;8(6):5222-5236. doi: 10.1002/ehf2.13601. Epub 2021 Sep 12.
3
Cardiac resynchronization therapy by left bundle branch area pacing in patients with heart failure and left bundle branch block.左束支区域起搏治疗心力衰竭伴左束支传导阻滞患者的心脏再同步治疗。
Heart Rhythm. 2019 Dec;16(12):1783-1790. doi: 10.1016/j.hrthm.2019.09.006. Epub 2019 Sep 9.
4
Non-invasive three-dimensional electrical activation mapping to predict cardiac resynchronization therapy response: site of latest left ventricular activation relative to pacing site.无创性三维电激活标测预测心脏再同步治疗反应:左心室最晚激活部位与起搏部位的关系。
Europace. 2023 Apr 15;25(4):1458-1466. doi: 10.1093/europace/euad041.
5
Acute biventricular hemodynamic effects of cardiac resynchronization therapy in right bundle branch block.心脏再同步治疗对右束支传导阻滞患者双心室血液动力学的急性影响。
Heart Rhythm. 2018 Oct;15(10):1525-1532. doi: 10.1016/j.hrthm.2018.05.017. Epub 2018 May 23.
6
Efficacy on resynchronization and longitudinal contractile function comparing His-bundle pacing with conventional biventricular pacing: a substudy to the His-alternative study.希氏束起搏与传统双心室起搏对再同步化及纵向收缩功能的疗效比较:希氏替代研究的亚研究。
Eur Heart J Cardiovasc Imaging. 2023 Dec 21;25(1):66-74. doi: 10.1093/ehjci/jead181.
7
Assessment of mechanical dyssynchrony in cardiac resynchronization therapy.心脏再同步治疗中机械性不同步的评估。
Dan Med J. 2014 Dec;61(12):B4981.
8
Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.心脏再同步治疗植入时右向左心室激活延迟时间延长与左束支传导阻滞患者临床结局改善相关。
Europace. 2016 Apr;18(4):550-9. doi: 10.1093/europace/euv117. Epub 2015 Jun 27.
9
His-Optimized Cardiac Resynchronization Therapy to Maximize Electrical Resynchronization: A Feasibility Study.心脏再同步优化治疗以最大化电学再同步:一项可行性研究。
Circ Arrhythm Electrophysiol. 2019 Feb;12(2):e006934. doi: 10.1161/CIRCEP.118.006934.
10
Non-invasive, model-based measures of ventricular electrical dyssynchrony for predicting CRT outcomes.用于预测心脏再同步治疗(CRT)效果的基于模型的无创心室电失同步测量方法。
Europace. 2016 Dec;18(suppl 4):iv104-iv112. doi: 10.1093/europace/euw356.

引用本文的文献

1
Concepts of Cardiac Dyssynchrony and Dynamic Approach.心脏不同步的概念与动态方法
Diagnostics (Basel). 2024 Apr 30;14(9):937. doi: 10.3390/diagnostics14090937.
2
25 years of basic and translational science in EP Europace: novel insights into arrhythmia mechanisms and therapeutic strategies.25 年的 EP Europace 基础与转化科学:心律失常机制和治疗策略的新见解。
Europace. 2023 Aug 25;25(8). doi: 10.1093/europace/euad210.

本文引用的文献

1
Tracking Early Systolic Motion for Assessing Acute Response to Cardiac Resynchronization Therapy in Real Time.实时追踪早期收缩期运动以评估心脏再同步治疗的急性反应
Front Physiol. 2022 Jun 2;13:903784. doi: 10.3389/fphys.2022.903784. eCollection 2022.
2
Shortening of time-to-peak left ventricular pressure rise (Td) in cardiac resynchronization therapy.左心室压力上升时间峰值缩短(Td)在心脏再同步治疗中的作用。
ESC Heart Fail. 2021 Dec;8(6):5222-5236. doi: 10.1002/ehf2.13601. Epub 2021 Sep 12.
3
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.
2021年欧洲心脏病学会心脏起搏与心脏再同步治疗指南。
Europace. 2022 Jan 4;24(1):71-164. doi: 10.1093/europace/euab232.
4
A multicenter prospective randomized controlled trial of cardiac resynchronization therapy guided by invasive dP/dt.一项由有创dP/dt指导的心脏再同步治疗的多中心前瞻性随机对照试验。
Heart Rhythm O2. 2021 Jan 22;2(1):19-27. doi: 10.1016/j.hroo.2021.01.005. eCollection 2021 Feb.
5
Determinants of LV dP/dt and QRS duration with different fusion strategies in cardiac resynchronisation therapy.不同心脏再同步治疗融合策略对左心室 dp/dt 和 QRS 持续时间的影响因素。
Open Heart. 2021 May;8(1). doi: 10.1136/openhrt-2021-001615.
6
Acute correction of electromechanical dyssynchrony and response to cardiac resynchronization therapy.机电失同步的急性校正和对心脏再同步治疗的反应。
ESC Heart Fail. 2020 Jun;7(3):1302-1308. doi: 10.1002/ehf2.12654. Epub 2020 Mar 11.
7
Left bundle branch block increases left ventricular diastolic pressure during tachycardia due to incomplete relaxation.左束支传导阻滞会导致左心室在心动过速时不完全松弛,从而增加左心室舒张末期压力。
J Appl Physiol (1985). 2020 Apr 1;128(4):729-738. doi: 10.1152/japplphysiol.01002.2018. Epub 2020 Jan 30.
8
Cardiac Resynchronization Therapy Optimization: A Comprehensive Approach.心脏再同步治疗优化:一种综合方法。
Cardiology. 2019;142(2):116-128. doi: 10.1159/000499192. Epub 2019 May 22.
9
Left ventricular end-systolic volume is a more sensitive marker of acute response to cardiac resynchronization therapy than contractility indices: insights from an experimental study.左心室收缩末期容积比收缩力指数更能敏感地反映心脏再同步治疗的急性反应:来自一项实验研究的见解。
Europace. 2019 Feb 1;21(2):347-355. doi: 10.1093/europace/euy221.
10
Multipoint pacing improves peripheral hemodynamic response: Noninvasive assessment using radial artery tonometry.多点起搏改善外周血流动力学反应:使用桡动脉压力测量法的无创评估。
Pacing Clin Electrophysiol. 2018 Feb;41(2):106-113. doi: 10.1111/pace.13254. Epub 2018 Jan 8.